Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #169553 on Biotech Values
jq1234
11/07/13 3:24 PM
#169557 RE: bladerunner1717 #169553
Overall response rate was 44%. This included five (28%) patients who met the BM and peripheral blood morphologic criteria for CR (n=4) or PR (n=1) and 3 patients with clinical improvement, pending validation of response duration and resolution of drug-induced grade-1 thrombocytopenia.
poorgradstudent
11/07/13 4:56 PM
#169567 RE: bladerunner1717 #169553
I suggest you (and iwai) read it and then tell us what you think.